Within the different AD-associated genes, the microglial triggering receptor expressed in myeloid cells 2 (TREM2) gene seems to perform a pivotal role in the AD-associated immune response (Ulrich et al., 2017; Yeh et al., 2017; Hansen et al., 2018). This evidence concerns the gene TREM2 and Alzheimer disease.